Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation

Biol Psychiatry. 1998 Nov 1;44(9):918-21. doi: 10.1016/s0006-3223(98)00004-3.

Abstract

Background: Changes in serotonin (5-HT) have been described in both Alzheimer's disease (AD) and aggressive/agitated behaviors. This paper explores a possible association between 5-HT deficits and agitation in AD, using prolactin response to d,1-fenfluramine administration as a probe for 5-HT activity.

Methods: Five AD patients with agitation and 5 without agitation received a 60-mg oral dose of d,1-fenfluramine. Prolactin levels were obtained at baseline, and 2 and 3 hours following administration.

Results: Change in prolactin levels from baseline to 3 hours was significantly larger among the agitated than the nonagitated Alzheimer's patients. Further, there was a positive and significant correlation between change in prolactin levels from baseline and level of agitation.

Conclusions: These findings suggest an association between 5-HT responsiveness and agitation in AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease* / classification
  • Alzheimer Disease* / complications
  • Alzheimer Disease* / physiopathology
  • Behavioral Symptoms / classification
  • Behavioral Symptoms / physiopathology
  • Biomarkers
  • Case-Control Studies
  • Female
  • Fenfluramine*
  • Humans
  • Male
  • Prolactin / blood
  • Prolactin / drug effects
  • Psychomotor Agitation* / etiology
  • Psychomotor Agitation* / physiopathology
  • Serotonin / physiology*
  • Serotonin Agents*

Substances

  • Biomarkers
  • Serotonin Agents
  • Fenfluramine
  • Serotonin
  • Prolactin